Starling Oncology STLN
NASDAQ STLN
$5.95 -0.14 (-2.22%)
As of: Sep 3, 2026 · 3:37 PM EDT

Starling Oncology (STLN) Cash from Financing Activities (2020 - 2026)

Analysis

Starling Oncology (STLN) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 HCA Healthcare 90.73 Bn 89.71 Bn 15.19 Bn -704.00 Mn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn -1.18 Bn
3 Encompass Health 12.13 Bn 12.00 Bn 1.34 Bn -76.90 Mn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn -270.19 Mn
5 Universal Health Services 10.12 Bn 9.98 Bn 3.29 Bn -189.49 Mn
6 Ensign 9.97 Bn 9.64 Bn 306.24 Mn -41.45 Mn
7 Chemed 6.91 Bn 6.87 Bn 221.47 Mn -33.21 Mn
8 Pacs 6.73 Bn 6.57 Bn 338.46 Mn -76.57 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.14 Bn 192.10 Mn -24.67 Mn
10 Starling Oncology 613.55 Mn 572.46 Mn 27.17 Mn -218,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -218,000.00
Mar 31, 2026 -28,000.00
Dec 31, 2025 3.73 Mn
Sep 30, 2025 10.60 Mn
Jun 30, 2025 1.96 Mn
Mar 31, 2025 -4.74 Mn
Dec 31, 2024 -164,000.00
Sep 30, 2024 -243,000.00
Jun 30, 2024 -2.15 Mn
Mar 31, 2024 -938,000.00
Dec 31, 2023 -1.78 Mn
Sep 30, 2023 -756,000.00
Jun 30, 2023 -2.60 Mn
Mar 31, 2023 -1.71 Mn
Dec 31, 2022 -847,000.00
Sep 30, 2022 105.40 Mn
Jun 30, 2022 -10.69 Mn
Mar 31, 2022 -1.66 Mn
Dec 31, 2021 136.13 Mn
Sep 30, 2021 -8,000.00